 |
0 Diseases |  |
1 Trial |
|
1 Trial |  |
1 News |  |
- || leuprorelin (CKD-841) / Chong Kun Dang
New P1 trial: The Safety and Pharmacokinetic/Pharmacodynamic Study of CKD-841 in Postmenopausal Female, Phase 1 (clinicaltrials.gov) - Apr 12, 2021
P1, N=32, Not yet recruiting, Sponsor: Chong Kun Dang Pharmaceutical